JXR (01951) announced that effective August 27, 2025, Dr. John G. Wilcox has resigned from his position as executive director, as well as his memberships on the nomination committee, strategic decision committee, and medical quality control and research development committee, in order to focus on his management role in the group's US operations. On the same date, Dr. Geng Lihong has been appointed as a member of the medical quality control and research development committee.